ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/04/15 | 1,990 | 2,036 | 1,973 | 2,030 | +10 | +0.5% | 449,800 |
2021/04/14 | 2,011 | 2,033 | 1,983 | 2,020 | +11 | +0.5% | 529,400 |
2021/04/13 | 2,018 | 2,056 | 1,998 | 2,009 | -21 | -1% | 549,300 |
2021/04/12 | 2,122 | 2,122 | 2,028 | 2,030 | -96 | -4.5% | 768,400 |
2021/04/09 | 2,104 | 2,146 | 2,104 | 2,126 | +22 | +1% | 463,500 |
2021/04/08 | 2,118 | 2,120 | 2,054 | 2,104 | -32 | -1.5% | 664,100 |
2021/04/07 | 2,173 | 2,187 | 2,117 | 2,136 | -39 | -1.8% | 650,100 |
2021/04/06 | 2,133 | 2,175 | 2,133 | 2,175 | +45 | +2.1% | 520,500 |
2021/04/05 | 2,115 | 2,162 | 2,092 | 2,130 | -1 | ±0% | 652,500 |
2021/04/02 | 2,209 | 2,218 | 2,120 | 2,131 | -74 | -3.4% | 869,300 |
2021/04/01 | 2,218 | 2,246 | 2,183 | 2,205 | +32 | +1.5% | 571,500 |
2021/03/31 | 2,187 | 2,222 | 2,152 | 2,173 | -9 | -0.4% | 568,700 |
2021/03/30 | 2,230 | 2,268 | 2,146 | 2,182 | -45 | -2% | 1,047,800 |
2021/03/29 | 2,335 | 2,345 | 2,195 | 2,227 | -121 | -5.2% | 1,253,800 |
2021/03/26 | 2,280 | 2,362 | 2,275 | 2,348 | +42 | +1.8% | 902,700 |
2021/03/25 | 2,380 | 2,400 | 2,222 | 2,306 | -68 | -2.9% | 1,763,400 |
2021/03/24 | 2,498 | 2,525 | 2,370 | 2,374 | -157 | -6.2% | 1,914,800 |
2021/03/23 | 2,436 | 2,564 | 2,418 | 2,531 | +102 | +4.2% | 1,940,300 |
2021/03/22 | 2,382 | 2,433 | 2,360 | 2,429 | +47 | +2% | 1,127,200 |
2021/03/19 | 2,265 | 2,385 | 2,257 | 2,382 | +67 | +2.9% | 1,418,700 |
2021/03/18 | 2,403 | 2,418 | 2,305 | 2,315 | -18 | -0.8% | 3,016,900 |
2021/03/17 | 2,358 | 2,400 | 2,270 | 2,333 | +171 | +7.9% | 2,700,400 |
2021/03/16 | 2,139 | 2,179 | 2,121 | 2,162 | +23 | +1.1% | 659,600 |
2021/03/15 | 2,094 | 2,152 | 2,061 | 2,139 | +44 | +2.1% | 684,300 |
2021/03/12 | 2,017 | 2,110 | 2,002 | 2,095 | +91 | +4.5% | 1,065,300 |
2021/03/11 | 1,974 | 2,010 | 1,946 | 2,004 | +20 | +1% | 629,700 |
2021/03/10 | 1,954 | 1,986 | 1,926 | 1,984 | +54 | +2.8% | 644,700 |
2021/03/09 | 1,917 | 1,951 | 1,863 | 1,930 | +16 | +0.8% | 892,200 |
2021/03/08 | 1,984 | 1,984 | 1,904 | 1,914 | -51 | -2.6% | 691,600 |
2021/03/05 | 1,971 | 1,971 | 1,895 | 1,965 | -11 | -0.6% | 932,700 |
2021/03/04 | 2,051 | 2,065 | 1,946 | 1,976 | -100 | -4.8% | 1,163,700 |
2021/03/03 | 2,001 | 2,082 | 2,000 | 2,076 | +60 | +3% | 866,000 |
2021/03/02 | 1,985 | 2,017 | 1,954 | 2,016 | +31 | +1.6% | 566,100 |
2021/03/01 | 1,980 | 1,998 | 1,925 | 1,985 | -26 | -1.3% | 858,700 |
2021/02/26 | 1,940 | 2,027 | 1,911 | 2,011 | +16 | +0.8% | 1,147,800 |
2021/02/25 | 1,915 | 1,995 | 1,909 | 1,995 | +109 | +5.8% | 862,700 |
2021/02/24 | 1,998 | 2,000 | 1,885 | 1,886 | -114 | -5.7% | 1,295,700 |
2021/02/22 | 2,000 | 2,012 | 1,974 | 2,000 | +18 | +0.9% | 681,000 |
2021/02/19 | 1,994 | 2,018 | 1,962 | 1,982 | -45 | -2.2% | 966,000 |
2021/02/18 | 2,077 | 2,117 | 2,006 | 2,027 | -20 | -1% | 1,088,100 |
2021/02/17 | 2,005 | 2,117 | 2,000 | 2,047 | +80 | +4.1% | 2,027,900 |
2021/02/16 | 2,015 | 2,043 | 1,958 | 1,967 | -50 | -2.5% | 1,387,700 |
2021/02/15 | 1,988 | 2,053 | 1,940 | 2,017 | -60 | -2.9% | 2,184,700 |
2021/02/12 | 2,203 | 2,221 | 2,077 | 2,077 | -155 | -6.9% | 2,558,600 |
2021/02/10 | 2,056 | 2,265 | 2,010 | 2,232 | +226 | +11.3% | 5,268,900 |
2021/02/09 | 2,396 | 2,399 | 1,948 | 2,006 | -399 | -16.6% | 5,015,000 |
2021/02/08 | 2,427 | 2,460 | 2,371 | 2,405 | -19 | -0.8% | 2,015,300 |
2021/02/05 | 2,341 | 2,436 | 2,327 | 2,424 | +124 | +5.4% | 2,200,500 |
2021/02/04 | 2,307 | 2,344 | 2,272 | 2,300 | -6 | -0.3% | 1,253,600 |
2021/02/03 | 2,218 | 2,315 | 2,214 | 2,306 | +76 | +3.4% | 1,252,300 |
851~
900
件表示中 / 3553件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
科研薬 | 386,000円 | +22.8% | +113.0% | 4.92% | 10.29倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 316,000円 | +14.7% | -21.6% | 1.90% | 12.35倍 | 1.00倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム